Spirocitromycetin, a Fungal Polyketide with an Antiosteoporotic Pharmacophore

Yong Chen,Ying Jie Wei,Nan Jiang,Hui Ming Ge,Rui Hua Jiao,Xu Cheng,Ren Xiang Tan
DOI: https://doi.org/10.1021/acs.jnatprod.1c01060
IF: 5.1
2022-05-05
Journal of Natural Products
Abstract:Spirocitromycetin, an antiosteoporotic polyketide bearing a unique spirocycle, was characterized from a human mucus sputum-derived <i>Penicillium velutinum</i>. Its structure and absolute configuration were elucidated spectrally, with its biosynthetic pathway likely mediated via polivione, a reported heptaketide. Spirocitromycetin was shown to be antiosteoporotic at 0.1 μM in the prednisolone-induced osteoporotic zebrafish model. A combination of spirocitromycetin variant synthesis and bioassay has identified 5'-methyl-3'<i>H</i>-spiro[chromane-3,2'-furan]-3',4-dione as an unreported antiosteroporotic pharmacophore. Collectively, this work offers new starting (sub)structures that may be of significance for antiosteoporotic drug discovery.
plant sciences,chemistry, medicinal,pharmacology & pharmacy
What problem does this paper attempt to address?